Astera Labs, Inc. Common Stock (NASDAQ:ALAB) Q4 2025 Earnings Call Transcript February 10, 2026 Astera Labs, Inc. Common Stock beats earnings expectations. Reported EPS is $0.58, expectations were $0.
BioRestorative completed a Type B meeting with the U.S. Food and Drug Administration ('FDA”) regarding a potential accelerated Biologics License Application ('BLA”) approval pathway for the Fast-Track ...
Prior to this call, DoubleDown issued its financial results for the fourth quarter of 2025 in a press release, a copy of ...
On this "Face the Nation with Margaret Brennan" broadcast, Sen. Mark Warner and Rep. Tony Gonzales join Margaret Brennan.
There were some changes to the recently updated OWASP Top 10 list, including the addition of supply chain risks. But old ...
Situations promoting uncertainty—including pregnancy, postpartum, parenting, or anything unknown—can help you harness and ...
As that headline suggested, the core of the argument was that the prohibition of marijuana was as wrong as the temporary prohibition of alcohol had been in the 20th century, and that Americans, at ...
Most teams only realize they need a backup policy after something goes wrong and by then, it’s too late. A clear, practical backup policy doesn’t just tick a compliance box; it keeps your business ...
Our comprehensive review of the Noise Luna Ring Gen 2, including analysis of the battery life, tracking accuracy, design, and more.
BioRestorative completed a Type B meeting with the U.S. Food and Drug Administration ("FDA") regarding a potential accelerated Biologics License Application ("BLA") approval pathway for the Fast-Track ...
Intercontinental Exchange, Inc. ( ICE) Q4 2025 Earnings Call February 5, 2026 8:30 AM EST Good morning, everyone, and thank ...
A worldwide shortage of diesel and jet fuel is forcing a reorganization of the global economy, leading to deglobalization and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results